Rho kinase inhibition with Fasudil in SOD1(G93A) mouse model of Amyotrophic 
Lateral Sclerosis - symptomatic treatment potential after diesease onset

Günther, René; Balck, Alexander; Koch, Jan C.; Nientiedt, Tobias; Sereda, Michael; Bähr, Mathias; Lingor, Paul; Tönges, Lars

doi:10.3389/fphar.2017.00017

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2405763_2

DetailsSummary

Released

Journal Article

Rho kinase inhibition with Fasudil in SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis - symptomatic treatment potential after diesease onset

MPS-Authors

/persons/resource/persons182328

Nientiedt, Tobias
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182406

Sereda, Michael
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Günther_17.pdf
(Any fulltext), 6MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Günther, R., Balck, A., Koch, J. C., Nientiedt, T., Sereda, M., Bähr, M., et al. (2017). Rho kinase inhibition with Fasudil in SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis - symptomatic treatment potential after diesease onset. Frontiers in Pharmacology, 8: 17. doi:10.3389/fphar.2017.00017.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-706E-1

Abstract

There is no abstract available